Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial by Andrés J. Daniele, Vanesa Gregorietti, Diego Costa, Teresa López – Fernández

Get full text

Severe cardiac events induced by combination immunotherapy in patients with cancer: a meta-analysis by German Valenzuela-Rodriguez, Carlos Diaz-Arocutipa, Jaime A. Collins, Teresa Lopez-Fernandez, Henry L. Gomez, Adrian V. Hernandez

Get full text

Percutaneous balloon mitral valvuloplasty and closure of the left atrial appendage: Synergy of two procedures in one percutaneous intervention by Daniele Gemma, Raúl Moreno Gómez, Jaime Fernández de Bobadilla, Guillermo Galeote García, Teresa López Fernandez, Jose R. López-Mínguez, José L. López-Sendón

Get full text

Social disparities in cardiovascular mortality of patients with cancer in the USA between 1999 and 2019 by Zahra Raisi-Estabragh, Ofer Kobo, Teresa López-Fernández, Husam Abdel Qadir, Nicholas WS. Chew, Wojtek Wojakowski, Abhishek Abhishek, Robert J.H. Miller, Mamas A. Mamas

Get full text

<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients by Alejandro Velasco-Ruiz, Rocio Nuñez-Torres, Guillermo Pita, Hans Wildiers, Diether Lambrechts, Sigrid Hatse, Danielle Delombaerde, Thomas Van Brussel, M. Rosario Alonso, Nuria Alvarez, Belen Herraez, Christof Vulsteke, Pilar Zamora, Teresa Lopez-Fernandez, Anna Gonzalez-Neira

Get full text